HBI
55
-4
KMX
46
-2
NWS
56
-2
APH
62
-6
ACN
38
-18
WDC
49
-4
CB
48
-3
PRU
67
3
DE
42
-4
WY
53
2
IVZ
52
-3
BXP
52
-5
NEM
28
-4
MSFT
54
-3
LEG
24
-5
ECL
60
-2
LOW
48
-2
EL
39
-6
FE
45
-3
MCD
50
-4
HBI
55
-4
KMX
46
-2
NWS
56
-2
APH
62
-6
ACN
38
-18
WDC
49
-4
CB
48
-3
PRU
67
3
DE
42
-4
WY
53
2
IVZ
52
-3
BXP
52
-5
NEM
28
-4
MSFT
54
-3
LEG
24
-5
ECL
60
-2
LOW
48
-2
EL
39
-6
FE
45
-3
MCD
50
-4
Financhill
Back

SELLAS Life Sciences Group Quote, Financials, Valuation and Earnings

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Sell
37

SLS
SELLAS Life Sciences Group

Last Price:
1.17
Seasonality Move:
1.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Investing Today: The Best Way To Grow A Small Account

In his free guide, expert Joe Duffy reveals... click here to read on...

SELLAS Life Sciences Group Price Quote

$1.17
-0.03 (-2.5%)
(Updated: October 31, 2024 at 6:55 PM ET)

SELLAS Life Sciences Group Key Stats

Sell
37
SELLAS Life Sciences Group (SLS) is a Sell
Day range:
$1.17 - $1.23
52-week range:
$0.50 - $1.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
27.05%
Volume:
690.4K
Avg. volume:
572K
1-year change:
3.45%
Market cap:
$78.8M
Revenue:
$0
EPS:
$-0.92

How Much Does SELLAS Life Sciences Group Make?

Data Unavailable

Is SELLAS Life Sciences Group Growing As A Company?

Data Unavailable

SELLAS Life Sciences Group Stock Price Performance

What Is SELLAS Life Sciences Group 52-Week High & Low?

SELLAS Life Sciences Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SELLAS Life Sciences Group?

Is SELLAS Life Sciences Group Cash Flow Positive?

  • What Is SLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$32.2M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $30.5M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

SELLAS Life Sciences Group Return On Invested Capital

Data Unavailable

SELLAS Life Sciences Group Earnings Date & Stock Price

SELLAS Life Sciences Group Competitors

SELLAS Life Sciences Group Dividend Yield

SELLAS Life Sciences Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 25%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.83
Upside from Last Price: 386.11%

Major Shareholders

  • How many SLS shares are owned by institutional investors?
    6.8M SLS shares are owned by institutional investors
  • How many SLS shares are owned by insiders?
    2.4M SLS shares are owned by insiders